BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29321800)

  • 1. Vascular protection by high-density lipoprotein-associated sphingosine-1-phosphate.
    Wang X; Wang F
    J Geriatr Cardiol; 2017 Nov; 14(11):696-702. PubMed ID: 29321800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
    Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis].
    Nádró B; Juhász L; Szentpéteri A; Páll D; Paragh G; Harangi M
    Orv Hetil; 2018 Feb; 159(5):168-175. PubMed ID: 29376427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
    Ruiz M; Okada H; Dahlbäck B
    Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system.
    Yao Mattisson I; Christoffersen C
    Atherosclerosis; 2021 Oct; 334():76-84. PubMed ID: 34482091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein M: bridging HDL and endothelial function.
    Christoffersen C; Nielsen LB
    Curr Opin Lipidol; 2013 Aug; 24(4):295-300. PubMed ID: 23652568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An engineered S1P chaperone attenuates hypertension and ischemic injury.
    Swendeman SL; Xiong Y; Cantalupo A; Yuan H; Burg N; Hisano Y; Cartier A; Liu CH; Engelbrecht E; Blaho V; Zhang Y; Yanagida K; Galvani S; Obinata H; Salmon JE; Sanchez T; Di Lorenzo A; Hla T
    Sci Signal; 2017 Aug; 10(492):. PubMed ID: 28811382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein from end-stage renal disease patients exhibits superior cardioprotection and increase in sphingosine-1-phosphate.
    Brinck JW; Thomas A; Brulhart-Meynet MC; Lauer E; Frej C; Dahlbäck B; Stenvinkel P; James RW; Frias MA
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29178180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-Phosphate and Atherosclerosis.
    Kurano M; Yatomi Y
    J Atheroscler Thromb; 2018 Jan; 25(1):16-26. PubMed ID: 28724841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-density lipoprotein, sphingosine 1-phosphate, and atherosclerosis.
    Nofer JR
    J Clin Lipidol; 2008 Feb; 2(1):4-11. PubMed ID: 21291709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate.
    Mishima Y; Kurano M; Kobayashi T; Nishikawa M; Ohkawa R; Tozuka M; Yatomi Y
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30279204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein M mediates sphingosine-1-phosphate efflux from erythrocytes.
    Christensen PM; Bosteen MH; Hajny S; Nielsen LB; Christoffersen C
    Sci Rep; 2017 Nov; 7(1):14983. PubMed ID: 29118354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.
    Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B
    J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection.
    Sattler K; Levkau B
    Cardiovasc Res; 2009 May; 82(2):201-11. PubMed ID: 19233866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
    Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR
    Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P).
    Potì F; Simoni M; Nofer JR
    Cardiovasc Res; 2014 Aug; 103(3):395-404. PubMed ID: 24891400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL.
    Egom EE; Mamas MA; Soran H
    Curr Opin Lipidol; 2013 Aug; 24(4):351-6. PubMed ID: 23652570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of sphingosine-1-phosphate in endothelial barrier function.
    Wilkerson BA; Argraves KM
    Biochim Biophys Acta; 2014 Oct; 1841(10):1403-1412. PubMed ID: 25009123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.
    Blaho VA; Galvani S; Engelbrecht E; Liu C; Swendeman SL; Kono M; Proia RL; Steinman L; Han MH; Hla T
    Nature; 2015 Jul; 523(7560):342-6. PubMed ID: 26053123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.